Epipolis-laser in situ keratomileusis (Epi-LASIK)

A review of the literature is presented regarding a new advanced surface ablation procedure, epipolis-laser in situ keratomileusis (Epi-LASIK). Histological findings suggest that the repositioning of the separated epithelial sheet might modulate corneal wound healing after photoablation. Recent clinical studies provide evidence that Epi-LASIK is an effective, safe and predictable method for the treatment of low-to-moderate myopia. However, like other surface treatments, slow visual recovery and postoperative discomfort remain drawbacks of Epi-LASIK in the early postoperative period. Large comparative studies between Epi-LASIK, photorefractive keratectomy and laser epithelial keratomileusis will draw conclusions about the possible advantages of Epi-LASIK over other photorefractive procedures.